Insmed: Insiders Dump Amid Market Uncertainty

This is a INSM news story, published by Yahoo Finance.

INSM news

For more INSM news, you can click here:

more INSM news

stocks trading & speculation news

For more stocks trading & speculation news, you can click here:

more stocks trading & speculation news

Yahoo Finance news

For more news from Yahoo Finance, you can click here:

more news from Yahoo Finance

About the Otherweb

Otherweb, Inc is a public benefit corporation, dedicated to improving the quality of news people consume. We are non-partisan, junk-free, and ad-free. We use artificial intelligence (AI) to remove junk from your news feed, and allow you to select the best business news, entertainment news, world news, and much more. If you like stocks trading & speculation news, you might also like this article about

Cap Stocks Insiders

. We are dedicated to bringing you the highest-quality news, junk-free and ad-free, about your favorite topics. Please come every day to read the latest Cap Stocks news, Cap Stock news, stocks trading & speculation news, and other high-quality news about any topic that interests you. We are working hard to create the best news aggregator on the web, and to put you in control of your news feed - whether you choose to read the latest news through our website, our news app, or our daily newsletter - all free!

large market caps

Insider Trading & Hedge Fund Data, and Investment Newsletter From Insider Monkey

•

Business

Business & Economics

Insmed Incorporated (INSM): Among the Large-Cap Stocks Insiders and Short Sellers Are Dumping Like Crazy

Summary

Nutrition label

76% Informative

Insmed Incorporated (NASDAQ: INSM ) is a biopharmaceutical firm located in New Jersey .

The company focuses on developing therapies for serious and rare diseases, including respiratory and inflammatory conditions.

Insiders and short sellers are dumping shares from multiple large-cap stocks.

Insmed Incorporated (NASDAQ: INSM ) has been expecting revenue from brensocatib but has rescheduled it to the third quarter of 2025 because of approval delays.

The company has a short float of 8.51% , putting the company under consistent pressure from bearish positions.

The steep 15.14% drop in insider ownership raises red flags about confidence in the company’s long-term pipeline.

VR Score

Informative language

Neutral language

Article tone

informal

Language

English

Language complexity

Offensive language

not offensive